U. ROCHESTER (US) —A drug widely used to treat arthritis offers better protection from non-melanoma skin cancers than sunscreen, research shows. The COX-2 inhibitor celecoxib (brand name Celebrex) led to a 62 percent reduction in non-melanoma skin cancers, which includes basal cell carcinomas and squamous cell carcinomas. The rate of decrease is much greater than that achieved through the use of s
![Skin cancer protection in a pill](https://cdn-ak-scissors.b.st-hatena.com/image/square/1ace7d5ba9c966dc3107746a10fa0cc1e9ebae43/height=288;version=1;width=512/https%3A%2F%2Fwww.futurity.org%2Fwp%2Fwp-content%2Fuploads%2F2011%2F01%2Fcapsule_celebrex_1.jpg)